Enright Williaminsider trades
In SEC Form 4 filings, Enright William is listed as Chief Executive Officer of Barinthus Biotherapeutics plc. (BRNS). Enright William reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 9.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| BRNSBarinthus Biotherapeutics plc. | Chief Executive Officer | 7 | Sep 9 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-09
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| BRNSBarinthus Biotherapeutics plc. | Sep 9 | Sep 9 | D | 728,454 | not reported | not reported | not reported | No | Form 4 |
| BRNSBarinthus Biotherapeutics plc. | Sep 9 | Sep 9 | D | 514,923 | not reported | not reported | not reported | No | Form 4 |
| BRNSBarinthus Biotherapeutics plc. | Sep 9 | Sep 9 | D · derivative | 176,130 | $17.00 | $2,994,210 | not reported | No | Form 4 |
| BRNSBarinthus Biotherapeutics plc. | Sep 9 | Sep 9 | D · derivative | 359,605 | $11.12 | $3,998,808 | not reported | No | Form 4 |
| BRNSBarinthus Biotherapeutics plc. | Sep 9 | Sep 9 | D · derivative | 440,000 | $2.40 | $1,056,000 | not reported | No | Form 4 |
| BRNSBarinthus Biotherapeutics plc. | Sep 9 | Sep 9 | D · derivative | 443,981 | $3.70 | $1,642,730 | not reported | No | Form 4 |
| BRNSBarinthus Biotherapeutics plc. | Sep 9 | Sep 9 | D · derivative | 600,000 | $1.00 | $600,000 | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.